{
  "docId": "019de073-e8d5-735f-8ffd-8a5102406a96",
  "docSlug": "3003a94fa3be7c8f2ff0fbac5a54b26e",
  "documentTitle": "Arbutus Biopharma | Results Presentation Deck | 15 slides",
  "authorId": "arbutus-biopharma",
  "authorName": "Arbutus Biopharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 15,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a bulleted list with circular icons to present key safety findings.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-e8d5-735f-8ffd-8a5102406a96/7",
  "deckHref": "/decks/019de073-e8d5-735f-8ffd-8a5102406a96",
  "deckJsonHref": "/decks/019de073-e8d5-735f-8ffd-8a5102406a96.json",
  "deckAnchorHref": "/decks/019de073-e8d5-735f-8ffd-8a5102406a96#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.485,
        "w": 0.804,
        "x": 0.076,
        "y": 0.245
      },
      "kind": "list",
      "text": "AB-729 generally safe and well-tolerated in clinical trial after single and repeat doses\nNo treatment-related SAEs or discontinuations due to AEs\nNo treatment-related Grade 3 or 4 AEs*\nNo treatment-related Grade 3 or 4 laboratory abnormalities*\nGrade 1 and Grade 2 ALT elevations have improved or stabilized with continued treatment\nInjection site TEAEs were mostly mild (erythema, pain, bruising, pruritis)\nNo clinically meaningful changes in ECGs or vital signs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "479416e4-ca2c-468f-90b1-e27813bc64d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.605,
        "x": 0.076,
        "y": 0.78
      },
      "kind": "source-note",
      "text": "*1 patient (Cohort A) with rapid decline in HBsAg of ~2.0 log10 IU/mL had an unrelated Gr 2 AE of food poisoning resulting in unrelated transient Grade 3 AEs of ALT/AST elevation (without bilirubin changes)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "820b21df-f58a-468b-8a1f-7a042f1aae96",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.38,
        "x": 0.31,
        "y": 0.94
      },
      "kind": "subtitle",
      "text": "AE: Adverse Event | TEAE: Treatment Emergent Adverse Event",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4ff27db0-f1cb-4afd-80c8-8fa35c437539",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.133,
        "w": 0.498,
        "x": 0.076,
        "y": 0.076
      },
      "kind": "title",
      "text": "AB-729-001 Safety Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6b4e759-880a-4d61-8912-d1bee8574232",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "7cd4531a-f980-4c0d-922c-d07b00af0a4d",
      "evidence": "list/bullet: AB-729 generally safe and well-tolerated in clinical trial after single and repeat doses",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}